Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): VacPertagen, pertussis vaccine (recombinant, acellular, component, adsorbed), Date of authorisation: 09/01/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Date of authorisation: 09/06/2000, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Insuman, insulin human, Date of authorisation: 21/02/1997, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Imatinib Teva, imatinib, Date of authorisation: 07/01/2013, Revision: 21, Status: Authorised

Variations not requiring assessment (veterinary medicines)

Transferring a veterinary marketing authorisation

Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)

Product-information requirements for veterinary medicines